Simpson-Herren L, Noker P E
Southern Research Institute, Birmingham, AL 35255-5305.
Cell Prolif. 1991 Jul;24(4):355-65. doi: 10.1111/j.1365-2184.1991.tb01164.x.
Failure of anti-cancer agents to reach all clonogenic cells at cytotoxic concentrations is recognized as an important form of resistance in solid tumours. Subcutaneously implanted mammary adenocarcinoma 16/C was used to evaluate the intratumour distribution of five alkylating, bioreductive alkylating and intercalating agents and two radiation sensitizers. The agents were classified according to their in vivo distribution in well- and poorly-perfused tumour regions, as delineated by lissamine green. The classifications were: (1) distribution in direct proportion to the vascular supply; (2) uniform distribution to well- and poorly-perfused tumour regions; and (3) preferential retention in the poorly-perfused tumour regions. Our current state of knowledge did not allow reliable prediction of the classification based on chemical structure or mechanism of action.
抗癌药物在细胞毒性浓度下未能到达所有克隆形成细胞被认为是实体瘤耐药的一种重要形式。皮下植入的乳腺腺癌16/C被用于评估五种烷化剂、生物还原烷化剂、嵌入剂以及两种辐射增敏剂在肿瘤内的分布。这些药物根据其在由丽丝胺绿描绘的灌注良好和灌注不良的肿瘤区域中的体内分布进行分类。分类如下:(1) 与血管供应成正比分布;(2) 均匀分布于灌注良好和灌注不良的肿瘤区域;(3) 优先滞留于灌注不良的肿瘤区域。我们目前的知识水平不允许基于化学结构或作用机制对分类进行可靠预测。